← Back to Search

Behavioural Intervention

Digital Therapeutic for Suicidal Ideation

N/A
Recruiting
Research Sponsored by University of Memphis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at intake, 3 months, 6 months, 9 months and 12 months
Awards & highlights

Study Summary

This trial aims to test the effectiveness of a digital platform called Aviva in providing cognitive-behavioral therapy to Servicemembers who have had recent suicidal thoughts or attempts. The Aviva platform

Who is the study for?
This trial is for Servicemembers with recent suicidal thoughts or attempts, who are seen in primary care clinics. They must have indicated a risk of suicide on specific assessments like the PHQ-9 and CSSRS Screener. Participants should be comfortable using smartphones but cannot join if they don't meet the clinic's criteria for suicide risk or can't follow the study procedures.Check my eligibility
What is being tested?
The trial tests Aviva, a digital version of Brief Cognitive Behavioral Therapy (BCBT), against standard safety planning and mental health care. Aviva aims to reduce suicidal ideation through an app over 8 weeks with features allowing revisiting treatment modules. Engagement with the app will also be analyzed for its impact on reducing suicidal thinking.See study design
What are the potential side effects?
Since Aviva is a digital therapeutic platform rather than medication, traditional side effects are not expected. However, participants may experience discomfort or emotional distress when engaging with therapy content related to their condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at intake, 3 months, 6 months, 9 months and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at intake, 3 months, 6 months, 9 months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self Injurious Thoughts and Behaviors Interview Revised
Secondary outcome measures
Beck Hopelessness Scale
Beck Scale for Suicide Ideation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital TherapeuticExperimental Treatment1 Intervention
BCBT Delivery via digital app
Group II: Treatment as UsualActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of MemphisLead Sponsor
70 Previous Clinical Trials
11,489 Total Patients Enrolled
1 Trials studying Suicidal Ideation
152 Patients Enrolled for Suicidal Ideation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for patient enrollment in the ongoing recruitment phase of this clinical trial?

"Yes, data listed on clinicaltrials.gov confirms that recruitment for this research is ongoing. It was initially published on 2nd July 2024 and last revised on 3rd November 2024. The study aims to enroll 400 participants at a single site."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

I have tried many drugs for my OCD/ depression and anxiety but none helped With my OCD and anxiety.
PatientReceived 2+ prior treatments
~267 spots leftby Aug 2027